BioLine RX Stock

BioLine RX EBIT per Share

The EBIT per Share of BioLine RX (BLRX.TA) as of Sep 2, 2026 is -0.02 USD. In the previous year, EBIT per Share was -0.04 USD — a change of -63.72% (higher).

EBIT per Share

-0.02USD

YoY

-63.72%

Last updated:

EBIT per Share of BioLine RX is 2026 -0.02 USD. EBIT per Share of BioLine RX was 2025 -0.04 USD. It decreases by -63.72% higher compared to the previous year.

The BioLine RX EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2017
-0.28 USD
Jan 1, 2018
-0.24 USD
Jan 1, 2019
-0.19 USD
Jan 1, 2020
-0.09 USD
Jan 1, 2021
-0.04 USD
Jan 1, 2022
-0.04 USD
Jan 1, 2023
-0.04 USD
Jan 1, 2024
-0.02 USD
The BioLine RX EBIT per Share history
YEAREBIT per ShareYoY
-0.02USD-63.72%
-0.04USD+18.46%
-0.04USD+0.80%
-0.04USD-58.78%
-0.09USD-52.77%
-0.19USD-18.57%
-0.24USD-15.95%
-0.28USD-4.62%
-0.29USD-6.65%
-0.32USD-40.46%
-0.53USD-29.96%
-0.76USD-39.61%
-1.25USD-5.78%
-1.33USD-569.59%
0.28USD-117.10%
-1.65USD-68.33%
-5.22USD+29.33%
-4.04USD+89.80%
-2.13USD+90.38%
-1.12USD—
Access this data via the Eulerpool API
Get Free API Key

BioLine RX Stock analysis

What does BioLine RX do? BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe. BioLine RX is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioLine RX stock

EBIT per Share of BioLine RX is -0.02 USD in 2026.

EBIT per Share of BioLine RX changed from -0.04 USD to -0.02 USD, representing a -63.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share BioLine RX since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — BioLine RX

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — BioLine RX